Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
West Central Gastroenterology d/b/a Gastro Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
GastroCare
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of North Carolina, LLC
mi
from
Durham, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor Gastroenterology Assoc
mi
from
Houston, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Orange County Institute of Gastroenterology & Endoscopy
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Specialists
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Washington / Harborview Medical Center; University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
The iResearch Group, LLC
mi
from
Southfield, MI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
DBC Research, Corp
mi
from
Tamarac, FL
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Non-Small-Cell Lung Carcinoma Clinical Trial
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Status: Enrolling, Phase III
Updated: 9/30/2015
Clinical Research Facility
mi
from
Wausau, WI
Click here to add this to my saved trials
Refractory Hurthle Cell Thyroid Cancer Clinical Trial
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Morristown, NJ
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Follicular Lymphoma Clinical Trial
Study of Duvelisib in Combination With Rituximab vs Rituximab in Subjects With Previously Treated Follicular Lymphoma
Status: Enrolling, Phase III
Updated: 11/2/2015
Clinical Research Facility
mi
from
Topeka, KS
Click here to add this to my saved trials
Neoplasms Clinical Trial
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Inova Fairfax Hospital Woodburn GYN Infusion Center
mi
from
Annandale, VA
Click here to add this to my saved trials
Neoplasms Clinical Trial
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
START Midwest
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Hollywood, MD
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Humble, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Kinston, NC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Sherwood, AR
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Bristol, CT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Reno, NV
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Southlake, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Urbana, IL
Click here to add this to my saved trials
Acute Hepatic Porphyria Clinical Trial
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Trial Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Heartland Cancer Center
mi
from
Great Bend, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-POB I
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Desert West Surgery
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UP Health System Hematology Oncology Marquette
mi
from
Marquette, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Virginia Clinic
mi
from
Virginia, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Wheaton Franciscan Healthcare-Saint Joseph/Wauwatosa Campus
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
William E Kahlert Regional Cancer Center/Sinai Hospital
mi
from
Westminster, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Wellspan Health - York Cancer Center
mi
from
York, PA
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Status: Enrolling
Updated: 12/31/1969
Abbott Northwestern Hospital - Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Heart Failure With Left Bundle Branch Block Clinical Trial
AdaptResponse Clinical Trial
Status: Enrolling, Phase IV
Updated: 12/31/1969
Florida Heart & Rhythm Specialists
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Heart Failure With Left Bundle Branch Block Clinical Trial
AdaptResponse Clinical Trial
Status: Enrolling, Phase IV
Updated: 12/31/1969
John Hunter Hospital
mi
from
New Lambton,
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
Status: Enrolling
Updated: 2/9/2018
University of Alberta Edmonton
mi
from
Edmonton,
Click here to add this to my saved trials
Osteoarthritis Clinical Trial
A Single Time-Point Study to Evaluate the ConforMIS iTotal® (CR) Knee Versus Off-the-Shelf
Status: Enrolling, Phase IV
Updated: 5/12/2016
Orthopedic Specialties of Spartanburg
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Status: Enrolling, Phase III
Updated: 5/4/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Status: Enrolling, Phase III
Updated: 5/4/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Status: Enrolling, Phase III
Updated: 5/4/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Status: Enrolling, Phase III
Updated: 5/4/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Lymphoma Clinical Trial
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
New York University Cancer Cen
mi
from
New York, NY
Click here to add this to my saved trials
Lymphoma Clinical Trial
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
St. Louis Univ Care Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Butte, MT
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Congenital Afibrinogenemia Clinical Trial
Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Patients With Congenital Afibrinogenemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
S.S. Institute of Medical Sciences and Research Centre
mi
from
Davangere,
Click here to add this to my saved trials
Early Breast Cancer Clinical Trial
A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer.
Status: Enrolling
Updated: 12/31/1969
Ashikari Breast Center
mi
from
Dobbs Ferry, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albemarle, NC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Amarillo, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
American Fork, UT
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Auburn, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Augusta, ME
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Site
mi
from
Baker City, OR
Click here to add this to my saved trials